| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6006750 | Clinical Neurology and Neurosurgery | 2013 | 8 Pages |
Abstract
While there remains a lack of consensus regarding the best approach to the management of patients with malignant epidermoid tumors, our systematic analysis characterizes and confirms the added benefit of SRS, chemotherapy, and multimodal adjuvant therapies.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Daniel T. Nagasawa, Winward Choy, Marko Spasic, Andrew Yew, Andy Trang, Heather M. Garcia, Isaac Yang,